We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAY
701
DELISTED
Dayforce
DAY
$636K ﹤0.01%
6,087
-938
-13% -$108K
FTS icon
702
Fortis
FTS
$29.7B
$616K ﹤0.01%
+12,749
New +$577K
WPM icon
703
Wheaton Precious Metals
WPM
$49.8B
$610K ﹤0.01%
14,209
-1,539
-10% -$63.4K
BXP icon
704
Boston Properties
BXP
$11.2B
$604K ﹤0.01%
5,245
-10,061
-66% -$1.16M
FNF icon
705
Fidelity National Financial
FNF
$14.6B
$597K ﹤0.01%
11,906
-4,624
-28% -$221K
TMCI icon
706
Treace Medical Concepts
TMCI
$260M
$596K ﹤0.01%
32,000
– –
RUN icon
707
Sunrun
RUN
$2.3B
$592K ﹤0.01%
17,268
+2,701
+19% +$126K
NHI icon
708
National Health Investors
NHI
$3.81B
$575K ﹤0.01%
10,000
– –
ALDX icon
709
Aldeyra Therapeutics
ALDX
$95.3M
$560K ﹤0.01%
140,000
– –
JEF icon
710
Jefferies Financial Group
JEF
$13.2B
$560K ﹤0.01%
15,100
-373
-2% -$14.4K
PBA icon
711
Pembina Pipeline
PBA
$29B
$552K ﹤0.01%
18,183
+3,306
+22% +$105K
WRK
712
DELISTED
WestRock Company
WRK
$551K ﹤0.01%
12,422
-6,600
-35% -$311K
FBC
713
DELISTED
Flagstar Bancorp, Inc. New
FBC
$529K ﹤0.01%
11,041
– –
UHAL icon
714
U-Haul Holding Co
UHAL
$14.3B
$521K ﹤0.01%
+7,180
New +$517K
QRVO icon
715
Qorvo
QRVO
$8.09B
$516K ﹤0.01%
3,298
-11,731
-78% -$1.87M
ITUB icon
716
Itaú Unibanco
ITUB
$91.6B
$503K ﹤0.01%
152,094
-42,600
-22% -$153K
HRTX icon
717
Heron Therapeutics
HRTX
$92M
$493K ﹤0.01%
53,993
-112,923
-68% -$1.15M
YUMC icon
718
Yum China
YUMC
$15.6B
$493K ﹤0.01%
9,900
-700
-7% -$38K
SE icon
719
Sea Limited
SE
$65.8B
$465K ﹤0.01%
2,077
+587
+39% +$175K
KGC icon
720
Kinross Gold
KGC
$28.1B
$464K ﹤0.01%
79,926
+34,857
+77% +$208K
BBD icon
721
Banco Bradesco
BBD
$38.3B
$457K ﹤0.01%
146,955
-16,475
-10% -$54.5K
DVA icon
722
DaVita
DVA
$15.4B
$440K ﹤0.01%
3,872
-19,416
-83% -$2.09M
TU icon
723
Telus
TU
$16.7B
$434K ﹤0.01%
18,403
-300
-2% -$6.86K
ZION icon
724
Zions Bancorporation
ZION
$10.1B
$430K ﹤0.01%
6,803
-344
-5% -$22K
FOXA icon
725
Fox Class A
FOXA
$24.2B
$414K ﹤0.01%
11,209
– –
27 28
29
30 31

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.